NCT05847036 Profiles of Urinary Tract Infections in General Practice

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2023-12-15 with a primary completion date of 2025-01-31.

Brief Summary

Urinary tract infections (UTIs) are one of the most common bacterial infections managed in general practice: they are the 2nd site of community-acquired bacterial infection after respiratory infections (4-6 million consultations per year in France). UTIs represent 15% of total antibiotic prescriptions in France. Antibiotics recommended for UTIs, except for cystitis, are considered as "critical" (highly generating bacterial resistances). UTIs are a potential source of antibiotic resistance: often inappropriate antibiotic prescriptions, evolution of the resistance profiles of the bacteria involved, emergence of multi-resistant strains. The first hypothesis is that there are other profiles of clinical UTI situations in general practice than typical cystitis or pyelonephritis, including intermediate forms. The second hypothesis is that these intermediate forms of UTI are subject to longer durations of antibiotherapy, and that probable explanatory factors need to be identified.

Eligibility Criteria

Inclusion Criteria: * Patient ≥18 years old * Patient presenting one or more of the following clinical signs suggestive of urinary tract infection in general practice consultation: * fever (temperature \> 38°C) * chills, sweats * burning urination * urinary urgency * pollakiuria * dysuria * lumbar and/or pelvic pain * abnormal urine appearance: cloudy, malodorous, macroscopic haematuria * absence of leucorrhoea * specifically in people \> 70 years old: * recent onset urinary incontinence * sudden confusion * bladder globe * Positive urine dipstick and/or positive Cytobacteriological Examination of Urine (CBEU) * Patient affiliated with the French National Health Insurance or beneficiary of such a scheme. * Patient's oral non-opposition of participation in the study after receiving complete information about the protocol Non-inclusion Criteria: * Patient \< 18 years old * Declared pregnancy * Patient with indwelling urinary catheter * Patient with functional or organic abnormality of the urinary tract * Patient with known severe immunodeficiency (HIV+ with CD4 count \< 200/mm3, organ transplant, bone marrow transplant, patient on immunosuppressants, cirrhosis) * Patient with known severe chronic renal failure (clearance \< 30 mL/min) * Patient previously treated with an antibiotic (for an other reason than a urinary tract infection and/or treatment failure of the urinary tract infection) in the past month before the inclusion consultation * Patient speaking little or no French * Patient with severe cognitive impairment * Patient with life expectancy \< 3 months * Patient under legal protection, inability to give an oral non-opposition * Patient with severity criteria justifying hospitalization

Contact & Investigator

Frequently Asked Questions

Related Trials